We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CITE
626
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
-203,921
Closed -$2.18M
BOCN
627
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
-543,790
Closed -$5.75M
AKTS
628
CALL
DELISTED
Akoustis Technologies Inc
AKTS
-100,000
Closed -$10K
PFTA
629
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
-231,102
Closed -$2.4M
THCP
630
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
-462,567
Closed -$4.68M
CNDA
631
DELISTED
Concord Acquisition Corp II
CNDA
-176,330
Closed -$1.81M
KCGI
632
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
-679,540
Closed -$7.18M
MORF
633
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-14,635
Closed -$768K
PEGR
634
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
-231,102
Closed -$2.39M
AONC
635
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
-142,301
Closed -$1.47M
PMGMW
636
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
-77,588
Closed -$1.95K
PMGM
637
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
-226,579
Closed -$2.39M
CBAY
638
CALL
DELISTED
Cymabay Therapeutics
CBAY
-75,000
Closed -$56.3K
FICV
639
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
-231,102
Closed -$2.39M
HHLA
640
DELISTED
HH&L Acquisition Co.
HHLA
-162,326
Closed -$1.7M
ELIQ
641
DELISTED
Electriq Power Holdings, Inc.
ELIQ
-229,199
Closed -$2.44M
KNSW
642
DELISTED
KnightSwan Acquisition Corporation
KNSW
-226,579
Closed -$2.39M
HWEL
643
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
-92,441
Closed -$950K
LOCC
644
DELISTED
Live Oak Crestview Climate Acquisition Corp.
LOCC
-499,180
Closed -$5.12M
ARTE
645
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
-369,763
Closed -$3.93M
NFNT
646
DELISTED
Infinite Acquisition Corp.
NFNT
-247,522
Closed -$2.62M
RVLP
647
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-254,736
Closed -$143K
FSNB
648
DELISTED
Fusion Acquisition Corp. II
FSNB
-443,821
Closed -$4.61M
FZT
649
DELISTED
FAST Acquisition Corp. II
FZT
-379,232
Closed -$3.95M
TRTN
650
DELISTED
Triton International Limited
TRTN
-746,927
Closed -$62.2M

Similar funds

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.